2016 discharge: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Having examined the revenue and expenditure accounts for the financial year 2016 and the balance sheet as at 31 December 2016 of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), as well as the Court of Auditors' report on the annual accounts of the Centre for the financial year 2016, accompanied by the Centre's replies to the Court's observations, the Council recommended the European Parliament to give a discharge to the Director of the Monitoring Centre in respect of the implementation of the budget for the financial year 2016.
The Council welcomed the Court's opinion that the Centre's annual accounts present fairly its financial position as at 31 December 2016 and the results of its operations and its cash flows for the year then ended, in accordance with the provisions of the Centre's Financial Regulation, and that the underlying transactions for 2016 are legal and regular in all material respects.
Nevertheless, the following observations were made:
- procurement: the Council welcomed the fact that the Centre continues to follow-up last year's observation in relation to the improvement of the Centre's central planning and monitoring of its procurements;
- IT issues: the Council called on the Centre to improve the management and long-term outlook of its IT projects, since shortcomings in this area could affect the Centre's core operational processes. It welcomed the fact that a plan to remedy the situation has already been agreed upon and encourages it being put into practice.